Business Context and Reporting Period
This Form 8-K, filed on February 21, 2024, by Bio-Rad Laboratories, Inc. (Bio-Rad), serves as a Regulation FD disclosure. It provides an update regarding Bio-Rad's investment in Sartorius AG, referencing Sartorius's financial results for the year ended December 31, 2023, which were publicly disclosed by Sartorius on February 16, 2024.
Key Financial Metrics (Sartorius AG)
The filing summarizes Sartorius AG's financial data for the year ended December 31, 2023, in millions of Euros (€), prepared under IFRS:
- Sales Revenue: €3,395.7
- Gross Profit: €1,567.1
- EBIT: €503.9
- Net Profit: €290.0
- Operating Cash Flow: €853.6
- Investing Cash Flow: (€2,823.3)
- Financing Cash Flow: €2,165.7
- Total Assets: €9,755.4 (Current: €1,956.9; Non-current: €7,798.5)
- Total Liabilities: €6,997.9 (Current: €1,330.0; Non-current: €5,667.9)
- Equity: €2,757.4
Material Changes
The filing does not provide comparative data for prior periods or explicitly state material changes versus previous years. It solely presents the absolute financial figures for the 2023 fiscal year as disclosed by Sartorius AG.
Guidance, Outlook, and Risks
Bio-Rad explicitly disclaims any responsibility or liability for errors or omissions in the Sartorius AG financial data referenced in this report. The filing directs investors to Sartorius AG's 2023 Annual Report for further details and notes that the Sartorius website is not incorporated by reference. No specific guidance or outlook from Bio-Rad management regarding the investment is provided in this document.
Investor Verification Checklist
- Verify the full 2023 Annual Report of Sartorius AG for detailed segment performance and risk factors.
- Confirm the exchange rate used to convert Sartorius's Euro-denominated results to USD for Bio-Rad's consolidated reporting.
- Review Bio-Rad's Form 10-K (filed February 16, 2024) for the original disclosure context regarding the Sartorius investment.
- Assess the impact of Sartorius's significant negative investing cash flow (€2,823.3 million) on its liquidity position.